At Richmond Research Institute, we are proud to align with the theme of this year’s World Patient Safety Day – “Improving Diagnosis for Patient Safety.” For over a decade, our research has focused on identifying patients at risk of Sudden Cardiac Death (SCD), with a specific emphasis on those with diabetes.
Did you know that people living with diabetes are 2 to 8 times more likely to suffer from sudden cardiac death? Our research investigates the complex interaction between glucose, insulin levels, and cardiotoxic drugs to better understand the characteristics that place patients at higher risk. Our goal is to develop preventative measures to protect patients and their families from the devastating impact of SCD.
One key finding from our research is the increased risk faced by Type 1 diabetics (insulin-dependent), particularly when high blood sugar levels combine with medicines that affect heart rhythm. This could offer a vital clue for avoiding SCD.
Our work continues as we explore the risks associated with Type 2 diabetes, where patients often experience delayed or impaired insulin release. This period of high blood glucose and low circulating insulin may elevate the danger for patients prescribed QT-prolonging medications.
At RRI, we are committed to using clinical research to enhance diagnosis and ultimately improve patient safety.
You can read our full study here: Effect of hyperglycaemia in combination with moxifloxacin on cardiac repolarization in Type 1 diabetes.
Join us in our mission to improve diagnosis for better patient outcomes.
.svg)
